眼科用粘弾性デバイスの世界市場の評価：製品タイプ別、組成別、用途別、エンドユーザー別、地域別、機会、予測（2017年～2031年）

世界の眼科用粘弾性デバイスの市場規模は、2023年に30億1,000万米ドル、2031年に44億8,000万米ドルに達し、2023年～2031年の予測期間にCAGRで5.1%の成長が見込まれています。世界の眼科用粘弾性デバイス市場は、眼科関連疾患の有病率の増加、老年人口の増加、眼科用デバイスの進歩などの主な要因によって大きな成長を示しています。加えて、ライフスタイルの変化、長いスクリーンタイム、慢性疾患の罹患率の上昇が、眼障害患者の増加に寄与し、眼科用粘弾性デバイスの需要を促進しています。

眼科用粘弾性デバイス市場は、白内障、緑内障、角膜移植、網膜硝子体手術などのさまざまな手術の需要の増加によって大きく成長すると予測されています。老年人口は特に視力障害を起こしやすいため、眼科用粘弾性デバイスのニーズがさらに高まっています。さらに、糖尿病や高血圧などの慢性疾患の流行も市場に影響を与えており、これらの疾患は眼障害を伴うことが多いです。技術の進歩、医療インフラを支援する政府の政策、医療機器の充実が市場の成長に拍車をかけています。しかし、手術後の眼圧上昇リスクや代替療法の存在といった課題が、市場拡大を阻害する可能性があります。

2023年4月、Bausch + Lomb CorporationはStableVisc cohesive OVDとTotalVisc Viscoelastic Systemの2つの粘弾性デバイスを米国市場で発売すると発表しました。どちらのデバイスもヒアルロン酸ナトリウムとソルビトールの混合物を含んでおり、強力な物理的バリアをもたらし、その他の入手可能な眼科用粘弾性デバイスと比較してフリーラジカル消去能力を高めています。

眼科疾患の有病率の上昇

屈折異常、白内障、糖尿病網膜症、緑内障、加齢黄斑変性（AMD）などの眼科疾患の有病率の増加は、世界の眼科用粘弾性デバイス（OVD）市場に大きな影響を与えています。これらの疾患は、不健康なライフスタイル、栄養不足、長いスクリーンタイムなどの要因により増加傾向にあります。これらの疾患の有病率の増加は、眼科手術に広く使用される眼科用粘弾性デバイスの需要を促進すると予測されます。2023年8月のWHOのファクトシートによると、世界で22億人が近視または遠視にを患っています。そのうち、遠方視覚障害による失明者は10億人で、その内訳は白内障9,400万人、屈折異常8,840万人、加齢黄斑変性800万人、緑内障770万人、糖尿病網膜症390万人です。8億2,600万人が罹患している老眼は、近見視力を損なう主な疾患です。

老年人口の増加

眼科用粘弾性デバイスのニーズの増加に大きく寄与しているもう1つの重要な側面は高齢化です。高齢者は目に影響を及ぼす慢性疾患や眼科疾患などの疾患を併発する傾向があります。WHOによると、2030年までに世界の6人に1人が60歳以上になります。2020年に10億人だった60歳以上の高齢者は、2030年までに14億人になります。2050年までに、地球上の60歳以上の人口は2倍の21億人になります。80歳以上の人口は2050年までに4倍の4億2,600万人になると予測されています。

凝集性眼科用粘弾性デバイスが優位に

予測期間に世界の眼科用粘弾性デバイスの中で、凝集性眼科用粘弾性デバイスセグメントが優位を占めると予測されます。凝集性眼科用粘弾性デバイスは、手術環境の安定性を高める高い粘度や、手術による除去を容易にする高い凝集性などの利点を提供するため、広く使用されています。これは構造を安定させ、それらが占める空間の加圧を可能にします。白内障の有病率の増加と眼科用粘弾性デバイスの技術の進歩が、凝集性眼科用粘弾性デバイスセグメントの優位性の理由です。市場企業は、この製品カテゴリで競争力を得るために製品ポートフォリオを拡大しています。

当レポートでは、世界の眼科用粘弾性デバイス市場について調査分析し、市場規模と予測、市場力学、主要企業情勢と見通しなどを提供しています。

目次

第1章 調査手法

第2章 プロジェクトの範囲と定義

第3章 エグゼクティブサマリー

第4章 世界の眼科用粘弾性デバイス市場の見通し（2017年～2031年）

• 市場規模と予測
  • 金額
  • 数量
• 製品タイプ別
  • 凝集性眼科用粘弾性デバイス
  • 分散性眼科用粘弾性デバイス
  • ビスコアダプティブ眼科用粘弾性デバイス
  • 高粘度分散性眼科用粘弾性デバイス
• 組成別
  • ヒアルロン酸ナトリウム
  • コンドロイチン硫酸
  • ヒドロキシプロピルメチルセルロース
• 用途別
  • 白内障手術
  • 緑内障手術
  • 網膜硝子体手術
  • 角膜移植手術
  • その他の用途
• エンドユーザー別
  • 病院
  • 眼科クリニック
  • 外来手術センター
  • 学術、研究機関
  • その他
• 地域別
  • 北米
  • 欧州
  • アジア太平洋
  • 南米
  • 中東・アフリカ
• 市場シェア：企業別（2023年）

第5章 世界の眼科用粘弾性デバイス市場：地域別（2017年～2031年）

• 北米
  • 市場規模と予測
  • 製品タイプ別
  • 組成別
  • 用途別
  • エンドユーザー別
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • フランス
  • イタリア
  • 英国
  • ロシア
  • オランダ
  • スペイン
  • トルコ
  • ポーランド
• 南米
  • ブラジル
  • アルゼンチン
• アジア太平洋
  • インド
  • 中国
  • 日本
  • オーストラリア
  • ベトナム
  • 韓国
  • インドネシア
  • フィリピン
• 中東・アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • イスラエル
  • 南アフリカ

第6章 市場マッピング（2023年）

• 製品タイプ別
• 組成別
• 用途別
• エンドユーザー別
• 地域別

第7章 マクロ環境と産業構造

• 需給分析
• 輸出入の分析 - 数量と金額
• サプライ/バリューチェーン分析
• PESTEL分析
• ポーターのファイブフォース分析

第8章 市場力学

• 成長促進要因
• 成長抑制要因（課題、抑制要因）

第9章 規制枠組みとイノベーション

• 臨床試験
• 特許情勢
• 規制当局の承認
• イノベーション/新技術

第10章 主要企業情勢

• マーケットリーダー上位5社の競合マトリクス
• マーケットリーダー上位5社の市場収益分析（2023年）
• 合併と買収/合弁事業（該当する場合）
• SWOT分析（市場参入企業5社）
• 特許分析（該当する場合）

第11章 価格分析

第12章 ケーススタディ

第13章 主要企業の見通し

• Johnson & Johnson Surgical Vision Inc.
• Alcon Laboratories, Inc.
• Carl Zeiss Meditec AG
• Rumex International Corporation
• Altacor Limited
• Bausch & Lomb Incorporated
• Novartis International AG
• CVC Capital Partners SICAV- FIS SA
• Eyekon Medical Inc.
• Bohus BioTech AB
• Beaver Visitec Limited
• Neu Micromed International Pvt. Ltd.
• Rayner Intraocular Lenses Limited

第14章 戦略的推奨事項

第15章 当社について、免責事項

List of Tables

• Table 1. Pricing Analysis of Products from Key Players
• Table 2. Competition Matrix of Top 5 Market Leaders
• Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
• Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

• Figure 1. Global Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 2. Global Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
• Figure 3. Global Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
• Figure 4. Global Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
• Figure 5. Global Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
• Figure 6. Global Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
• Figure 7. Global Ophthalmic Viscoelastic Devices Market Share (%), By Region, 2017-2031F
• Figure 8. North America Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 9. North America Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
• Figure 10. North America Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
• Figure 11. North America Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
• Figure 12. North America Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
• Figure 13. North America Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
• Figure 14. North America Ophthalmic Viscoelastic Devices Market Share (%), By Country, 2017-2031F
• Figure 15. United States Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 16. United States Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
• Figure 17. United States Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
• Figure 18. United States Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
• Figure 19. United States Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
• Figure 20. United States Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
• Figure 21. Canada Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 22. Canada Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
• Figure 23. Canada Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
• Figure 24. Canada Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
• Figure 25. Canada Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
• Figure 26. Canada Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
• Figure 27. Mexico Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 28. Mexico Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
• Figure 29. Mexico Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
• Figure 30. Mexico Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
• Figure 31. Mexico Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
• Figure 32. Mexico Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
• Figure 33. Europe Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 34. Europe Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
• Figure 35. Europe Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
• Figure 36. Europe Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
• Figure 37. Europe Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
• Figure 38. Europe Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
• Figure 39. Europe Ophthalmic Viscoelastic Devices Market Share (%), By Country, 2017-2031F
• Figure 40. Germany Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 41. Germany Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
• Figure 42. Germany Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
• Figure 43. Germany Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
• Figure 44. Germany Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
• Figure 45. Germany Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
• Figure 46. France Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 47. France Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
• Figure 48. France Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
• Figure 49. France Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
• Figure 50. France Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
• Figure 51. France Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
• Figure 52. Italy Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 53. Italy Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
• Figure 54. Italy Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
• Figure 55. Italy Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
• Figure 56. Italy Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
• Figure 57. Italy Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
• Figure 58. United Kingdom Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 59. United Kingdom Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
• Figure 60. United Kingdom Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
• Figure 61. United Kingdom Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
• Figure 62. United Kingdom Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
• Figure 63. United Kingdom Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
• Figure 64. Russia Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 65. Russia Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
• Figure 66. Russia Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
• Figure 67. Russia Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
• Figure 68. Russia Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
• Figure 69. Russia Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
• Figure 70. Netherlands Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 71. Netherlands Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
• Figure 72. Netherlands Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
• Figure 73. Netherlands Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
• Figure 74. Netherlands Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
• Figure 75. Netherlands Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
• Figure 76. Spain Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 77. Spain Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
• Figure 78. Spain Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
• Figure 79. Spain Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
• Figure 80. Spain Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
• Figure 81. Spain Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
• Figure 82. Turkey Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 83. Turkey Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
• Figure 84. Turkey Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
• Figure 85. Turkey Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
• Figure 86. Turkey Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
• Figure 87. Turkey Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
• Figure 88. Poland Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 89. Poland Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
• Figure 90. Poland Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
• Figure 91. Poland Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
• Figure 92. Poland Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
• Figure 93. Poland Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
• Figure 94. South America Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 95. South America Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
• Figure 96. South America Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
• Figure 97. South America Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
• Figure 98. South America Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
• Figure 99. South America Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
• Figure 100. South America Ophthalmic Viscoelastic Devices Market Share (%), By Country, 2017-2031F
• Figure 101. Brazil Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 102. Brazil Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
• Figure 103. Brazil Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
• Figure 104. Brazil Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
• Figure 105. Brazil Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
• Figure 106. Brazil Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
• Figure 107. Argentina Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 108. Argentina Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
• Figure 109. Argentina Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
• Figure 110. Argentina Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
• Figure 111. Argentina Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
• Figure 112. Argentina Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
• Figure 113. Asia-Pacific Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 114. Asia-Pacific Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
• Figure 115. Asia-Pacific Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
• Figure 116. Asia-Pacific Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
• Figure 117. Asia-Pacific Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
• Figure 118. Asia-Pacific Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
• Figure 119. Asia-Pacific Ophthalmic Viscoelastic Devices Market Share (%), By Country, 2017-2031F
• Figure 120. India Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 121. India Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
• Figure 122. India Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
• Figure 123. India Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
• Figure 124. India Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
• Figure 125. India Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
• Figure 126. China Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 127. China Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
• Figure 128. China Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
• Figure 129. China Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
• Figure 130. China Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
• Figure 131. China Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
• Figure 132. Japan Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 133. Japan Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
• Figure 134. Japan Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
• Figure 135. Japan Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
• Figure 136. Japan Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
• Figure 137. Japan Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
• Figure 138. Australia Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 139. Australia Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
• Figure 140. Australia Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
• Figure 141. Australia Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
• Figure 142. Australia Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
• Figure 143. Australia Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
• Figure 144. Vietnam Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 145. Vietnam Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
• Figure 146. Vietnam Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
• Figure 147. Vietnam Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
• Figure 148. Vietnam Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
• Figure 149. Vietnam Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
• Figure 150. South Korea Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 151. South Korea Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
• Figure 152. South Korea Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
• Figure 153. South Korea Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
• Figure 154. South Korea Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
• Figure 155. South Korea Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
• Figure 156. Indonesia Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 157. Indonesia Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
• Figure 158. Indonesia Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
• Figure 159. Indonesia Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
• Figure 160. Indonesia Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
• Figure 161. Indonesia Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
• Figure 162. Philippines Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 163. Philippines Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
• Figure 164. Philippines Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
• Figure 165. Philippines Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
• Figure 166. Philippines Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
• Figure 167. Philippines Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
• Figure 168. Middle East & Africa Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 169. Middle East & Africa Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
• Figure 170. Middle East & Africa Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
• Figure 171. Middle East & Africa Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
• Figure 172. Middle East & Africa Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
• Figure 173. Middle East & Africa Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
• Figure 174. Middle East & Africa Ophthalmic Viscoelastic Devices Market Share (%), By Country, 2017-2031F
• Figure 175. Saudi Arabia Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 176. Saudi Arabia Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
• Figure 177. Saudi Arabia Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
• Figure 178. Saudi Arabia Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
• Figure 179. Saudi Arabia Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
• Figure 180. Saudi Arabia Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
• Figure 181. UAE Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 182. UAE Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
• Figure 183. UAE Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
• Figure 184. UAE Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
• Figure 185. UAE Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
• Figure 186. UAE Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
• Figure 187. South Africa Ophthalmic Viscoelastic Devices Market, By Value, In USD Billion, 2017-2031F
• Figure 188. South Africa Ophthalmic Viscoelastic Devices Market, By Volume, In Million Units, 2017-2031F
• Figure 189. South Africa Ophthalmic Viscoelastic Devices Market Share (%), By Product Type, 2017-2031F
• Figure 190. South Africa Ophthalmic Viscoelastic Devices Market Share (%), By Composition, 2017-2031F
• Figure 191. South Africa Ophthalmic Viscoelastic Devices Market Share (%), By Application, 2017-2031F
• Figure 192. South Africa Ophthalmic Viscoelastic Devices Market Share (%), By End-user, 2017-2031F
• Figure 193. By Product Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 194. By Composition Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 195. By Application Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 196. By End-user Map-Market Size (USD Billion) & Growth Rate (%), 2023
• Figure 197. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023

Global ophthalmic viscoelastic devices market size was valued at USD 3.01 billion in 2023 and is expected to reach USD 4.48 billion in 2031, with a CAGR of 5.1% for the forecast period between 2023 and 2031F. The global market for ophthalmic viscoelastic devices is experiencing significant growth due to several key factors, such as the increasing prevalence of eye-related disorders, the growing elderly population, and advancements in ophthalmic devices. Additionally, lifestyle changes, prolonged screen time, and the rising incidence of chronic diseases contribute to more patients with eye disorders, driving the demand for ophthalmic viscoelastic devices.

The ophthalmic viscoelastic devices market is projected to grow substantially, driven by the increasing demand for various surgical procedures, including those related to cataracts, glaucoma, corneal transplantation, and vitreoretinal surgery. The geriatric population is particularly susceptible to vision impairment, further boosting the need for ophthalmic viscoelastic devices. Furthermore, the market is influenced by the prevalence of chronic conditions such as diabetes and hypertension, which are often associated with eye disorders. Technological advancements, government policies supporting healthcare infrastructure, and enhanced availability of medical devices are fueling the market growth. However, challenges such as the risk of a rise in ocular pressure after surgery and the presence of alternative therapies may impede market expansion.

In April 2023, Bausch + Lomb Corporation announced the launch of two viscoelastic devices, StableVisc cohesive ophthalmic viscosurgical device (OVD) and TotalVisc Viscoelastic System, in the United States market. Both the devices contain a mix of sodium hyaluronate and sorbitol, providing a strong physical barrier and delivering increased free radical scavenging capabilities compared to other available ophthalmic viscoelastic devices.

Rising Prevalence of Ophthalmic Disorders

The increasing prevalence of ophthalmic disorders, such as refractive errors, cataracts, diabetic retinopathy, glaucoma, and age-related macular degeneration (AMD), significantly impacts the global ophthalmic viscoelastic devices (OVDs) market. These disorders are on the rise due to factors like unhealthy lifestyles, nutritional deficiency, and longer screen time. The increasing prevalence of these diseases is expected to drive the demand for ophthalmic viscoelastic devices, as these devices are extensively used in ophthalmic surgeries. A WHO factsheet from August 2023 states that 2.2 billion people worldwide suffer from near or far-sightedness. Out of which, 1 billion are affected by blindness from distance vision impairment, including 94 million people with cataracts, 88.4 million with refractive error, 8 million with age-related macular degeneration, 7.7 million with glaucoma, and 3.9 million with diabetic retinopathy. Presbyopia, which affects 826 million people, is the main condition that impairs close vision.

Growing Geriatric Population

Another important aspect that has contributed significantly to the increased need for ophthalmic viscoelastic devices is the aging population. People who are older tend to have comorbid ailments such as chronic illnesses and ophthalmic disorders that affect their eyes. As per WHO, by 2030, one in six people in the world will be 60 years of age or older. By 2030, there will be 1.4 billion over-60s, compared to 1 billion in 2020. By 2050, there will be twice as many people 60 years or older on the planet, i.e., 2.1 billion people. It is projected that the population of 80 years of age or older will quadruple to 426 million by 2050.

Cohesive Ophthalmic Viscoelastic Devices to Dominate

The cohesive ophthalmic viscoelastic devices segment in global ophthalmic viscoelastic devices is expected to dominate during the forecast period. Cohesive ophthalmic viscoelastic devices are being used extensively as they offer advantages such as high viscosity, which increases the stability of the surgical environment, and high cohesion, which eases surgical removal. It stabilizes structures and enables pressurization of the space they occupy. The growing prevalence of cataracts and technological advancements in ophthalmic viscoelastic devices are reasons for the dominance of the cohesive ophthalmic viscoelastic devices segment. Market players are expanding their product portfolio to gain a competitive edge in this product category.

North America is Expected to Dominate

With high investment in research and development activities, technological advancements by key players, and advanced healthcare infrastructure in countries, like the United States and Canada, the region is expected to dominate the market with the highest value share. Supportive government initiatives for managing the growing number of ophthalmic surgeries are embracing the growth of the market in the region. High disposable income and preference for ophthalmic treatments of eye problems, along with the presence of key players, are contributing to the dominance of North America in the ophthalmic viscoelastic devices market.

Future Market Scenario

Growth in healthcare infrastructure in developing countries and efforts to reduce the burden of ophthalmic disorders like integrated people-centered eye care (IPEC) by WHO is expected to set a positive trend for the market. Key market players focus on developing innovative products and expanding their market presence. In terms of regional growth, Asia-Pacific market is expected to experience a robust CAGR, driven by its sizable population, rising disposable income, and growing patient awareness of the need for eye care. In the future, surgeons might be able to carry out more intricate and accurate surgeries, and viscoelastic devices might be utilized to operate a wider range of ocular ailments.

Key Players Landscape and Outlook

The global ophthalmic viscoelastic devices market consists of market players like Bausch & Lomb Incorporated, Alcon Laboratories, Inc., Johnson & Johnson Surgical Vision Inc., and others, who are expanding their product offerings and giving their customers access to a wide range of cutting-edge and novel products.

For instance, In January 2022, Glaukos Corporation announced that it received 510(k) clearance from the United States Food and Drug Administration (FDA) for its viscoelastic device named 'iPRIME Viscodelivery System'. Glaukos is an ophthalmic medtech and pharmaceutical company dedicated to developing novel therapies for managing glaucoma, retinal diseases, and corneal disorders. iPRIME Viscodelivery System is a single-use, sterile, minimally-invasive device for delivering viscoelastic fluid during ophthalmic surgeries.

Table of Contents

1. Research Methodology

2. Project Scope & Definitions

3. Executive Summary

4. Global Ophthalmic Viscoelastic Devices Market Outlook, 2017-2031F

• 4.1. Market Size & Forecast
  • 4.1.1. By Value
  • 4.1.2. By Volume
• 4.2. By Product Type
  • 4.2.1. Cohesive Ophthalmic Viscoelastic Devices
  • 4.2.2. Dispersive Ophthalmic Viscoelastic Devices
  • 4.2.3. Viscoadaptive Ophthalmic Viscoelastic Devices
  • 4.2.4. Higher Viscosity Dispersive Ophthalmic Viscoelastic Devices
• 4.3. By Composition
  • 4.3.1. Sodium Hyaluronate
  • 4.3.2. Chondroitin Sulfate
  • 4.3.3. Hydroxypropyl Methylcellulose
• 4.4. By Application
  • 4.4.1. Cataract Surgery
  • 4.4.2. Glaucoma Surgery
  • 4.4.3. Vitreoretinal Surgery
  • 4.4.4. Corneal Transplantation Surgery
  • 4.4.5. Other Applications
• 4.5. By End-user
  • 4.5.1. Hospitals
  • 4.5.2. Eye Clinics
  • 4.5.3. Ambulatory Surgical Centers
  • 4.5.4. Academic and Research Institutes
  • 4.5.5. Others
• 4.6. By Region
  • 4.6.1. North America
  • 4.6.2. Europe
  • 4.6.3. Asia Pacific
  • 4.6.4. South America
  • 4.6.5. Middle East & Africa
• 4.7. By Company Market Share (%), 2023

5. Global Ophthalmic Viscoelastic Devices Market, By Region, 2017-2031F

• 5.1. North America*
  • 5.1.1. Market Size & Forecast
    • 5.1.1.1. By Value
    • 5.1.1.2. By Volume
  • 5.1.2. By Product Type
    • 5.1.2.1. Cohesive Ophthalmic Viscoelastic Devices
    • 5.1.2.2. Dispersive Ophthalmic Viscoelastic Devices
    • 5.1.2.3. Viscoadaptive Ophthalmic Viscoelastic Devices
    • 5.1.2.4. Higher Viscosity Dispersive Ophthalmic Viscoelastic Devices
  • 5.1.3. By Composition
    • 5.1.3.1. Sodium Hyaluronate
    • 5.1.3.2. Chondroitin Sulfate
    • 5.1.3.3. Hydroxypropyl Methylcellulose
  • 5.1.4. By Application
    • 5.1.4.1. Cataract Surgery
    • 5.1.4.2. Glaucoma Surgery
    • 5.1.4.3. Vitreoretinal Surgery
    • 5.1.4.4. Corneal Transplantation Surgery
    • 5.1.4.5. Other Applications
  • 5.1.5. By End-user
    • 5.1.5.1. Hospitals
    • 5.1.5.2. Eye Clinics
    • 5.1.5.3. Ambulatory Surgical Centers
    • 5.1.5.4. Academic and Research Institutes
    • 5.1.5.5. Others
  • 5.1.6. United States*
    • 5.1.6.1. Market Size & Forecast
    • 5.1.6.1.1. By Value
    • 5.1.6.1.2. By Volume
    • 5.1.6.2. By Product Type
    • 5.1.6.2.1. Cohesive Ophthalmic Viscoelastic Devices
    • 5.1.6.2.2. Dispersive Ophthalmic Viscoelastic Devices
    • 5.1.6.2.3. Viscoadaptive Ophthalmic Viscoelastic Devices
    • 5.1.6.2.4. Higher Viscosity Dispersive Ophthalmic Viscoelastic Devices
    • 5.1.6.3. By Composition
    • 5.1.6.3.1. Sodium Hyaluronate
    • 5.1.6.3.2. Chondroitin Sulfate
    • 5.1.6.3.3. Hydroxypropyl Methylcellulose
    • 5.1.6.4. By Application
    • 5.1.6.4.1. Cataract Surgery
    • 5.1.6.4.2. Glaucoma Surgery
    • 5.1.6.4.3. Vitreoretinal Surgery
    • 5.1.6.4.4. Corneal Transplantation Surgery
    • 5.1.6.4.5. Other Applications
    • 5.1.6.5. By End-user
    • 5.1.6.5.1. Hospitals
    • 5.1.6.5.2. Eye Clinics
    • 5.1.6.5.3. Ambulatory Surgical Centers
    • 5.1.6.5.4. Academic and Research Institutes
    • 5.1.6.5.5. Others
  • 5.1.7. Canada
  • 5.1.8. Mexico

All segments will be provided for all regions and countries covered:

• 5.2. Europe
  • 5.2.1. Germany
  • 5.2.2. France
  • 5.2.3. Italy
  • 5.2.4. United Kingdom
  • 5.2.5. Russia
  • 5.2.6. Netherlands
  • 5.2.7. Spain
  • 5.2.8. Turkey
  • 5.2.9. Poland
• 5.3. South America
  • 5.3.1. Brazil
  • 5.3.2. Argentina
• 5.4. Asia-Pacific
  • 5.4.1. India
  • 5.4.2. China
  • 5.4.3. Japan
  • 5.4.4. Australia
  • 5.4.5. Vietnam
  • 5.4.6. South Korea
  • 5.4.7. Indonesia
  • 5.4.8. Philippines
• 5.5. Middle East & Africa
  • 5.5.1. Saudi Arabia
  • 5.5.2. UAE
  • 5.5.3. Israel
  • 5.5.4. South Africa

6. Market Mapping, 2023

• 6.1. By Product Type
• 6.2. By Composition
• 6.3. By Application
• 6.4. By End-user
• 6.5. By Region

7. Macro Environment and Industry Structure

• 7.1. Supply Demand Analysis
• 7.2. Import Export Analysis - Volume and Value
• 7.3. Supply/Value Chain Analysis
• 7.4. PESTEL Analysis
  • 7.4.1. Political Factors
  • 7.4.2. Economic System
  • 7.4.3. Social Implications
  • 7.4.4. Technological Advancements
  • 7.4.5. Environmental Impacts
  • 7.4.6. Legal Compliances and Regulatory Policies (Statutory Bodies Included)
• 7.5. Porter's Five Forces Analysis
  • 7.5.1. Supplier Power
  • 7.5.2. Buyer Power
  • 7.5.3. Substitution Threat
  • 7.5.4. Threat from New Entrant
  • 7.5.5. Competitive Rivalry

8. Market Dynamics

• 8.1. Growth Drivers
• 8.2. Growth Inhibitors (Challenges, Restraints)

9. Regulatory Framework and Innovation

• 9.1. Clinical Trials
• 9.2. Patent Landscape
• 9.3. Regulatory Approvals
• 9.4. Innovations/Emerging Technologies

10. Key Players Landscape

• 10.1. Competition Matrix of Top Five Market Leaders
• 10.2. Market Revenue Analysis of Top Five Market Leaders (in %, 2023)
• 10.3. Mergers and Acquisitions/Joint Ventures (If Applicable)
• 10.4. SWOT Analysis (For Five Market Players)
• 10.5. Patent Analysis (If Applicable)

11. Pricing Analysis

12. Case Studies

13. Key Players Outlook

• 13.1. Johnson & Johnson Surgical Vision Inc.
  • 13.1.1. Company Details
  • 13.1.2. Key Management Personnel
  • 13.1.3. Products & Services
  • 13.1.4. Financials (As reported)
  • 13.1.5. Key Market Focus & Geographical Presence
  • 13.1.6. Recent Developments
• 13.2. Alcon Laboratories, Inc.
• 13.3. Carl Zeiss Meditec AG
• 13.4. Rumex International Corporation
• 13.5. Altacor Limited
• 13.6. Bausch & Lomb Incorporated
• 13.7. Novartis International AG
• 13.8. CVC Capital Partners SICAV- FIS SA
• 13.9. Eyekon Medical Inc.
• 13.10. Bohus BioTech AB
• 13.11. Beaver Visitec Limited
• 13.12. Neu Micromed International Pvt. Ltd.
• 13.13. Rayner Intraocular Lenses Limited

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

14. Strategic Recommendations

15. About Us & Disclaimer